TECX

Insider Trades

Name	Value	Action	Price	Current Price
Ruddy Marcella K.Chief Medical Officer $32k1.1k shares SellMay 4, 2026 $30.00 --
Ruddy Marcella K.Chief Medical Officer $31k1k shares SellApr 1, 2026 $31.05 --
Ruddy Marcella K.Chief Medical Officer $300k10k shares SellMar 6, 2026 $30.00 --
McNamara PeterChief Scientific Officer $181k6k shares SellMar 6, 2026 $30.00 --
McNamara PeterChief Scientific Officer $7.5k215 shares SellMar 6, 2026 $35.00 --
McNamara PeterChief Scientific Officer $41k1.7k shares SellMar 4, 2026 $25.00 --

News

globenewswire.comTectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlightsglobenewswire.comMay 7

globenewswire.comTectonic Therapeutic Appoints Jessica Chutter to Board of Directorsglobenewswire.comApr 23

seekingalpha.comTectonic Therapeutic: A $1B+ Opportunity Hinges On Upcoming Phase 2seekingalpha.comApr 16

defenseworld.netTectonic Therapeutic, Inc. (NASDAQ:TECX) Receives $81.50 Consensus Price Target from Analystsdefenseworld.netApr 7

defenseworld.netAberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECXdefenseworld.netApr 6

Trade TECX

About Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.

CEO: Alise S. Reicin
IPO Date: Jun 21, 2018

Market Data

Open: $30.82
High: $31.31
Low: $29.38
Volume: 100.6K
Avg Volume: 201.1K
52W High: $36.03
52W Low: $14.39

Valuation

Market Cap: $566M
Enterprise Value: $334M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-60M
Revenue: $0
Net Income: $-74M
Cash: $254M
Debt: $1.3M

Events

EarningsAug 6

EPS est. -1.37